DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

The following faculty/staff members have the following financial relationships with ineligible companies.

April Armstrong, MD, MPH, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: AbbVie, Almirall, Arcutis, ASLAN, Beiersdorf, Boehringer Ingelheim, EPI Health, Incyte, Nimbus, Parexel, Pfizer, Regeneron, Sun Pharma, and UCB. Grant/Research Support: BMS, Dermavant, Dermira, Lilly, Galderma USA, Janssen, LEO, Modernizing Medicine, Novartis, Ortho Derm, Pfizer, Sanofi, and UCB. Speaker’s Bureau: Abbvie, Sanofi.

Hilary Baldwin, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant/Speaker’s List: Almirall, Bausch Health, Galderma, EPI, La Roche-Posay and SUN Pharma. Consultant: Journey. Speaker’s List: Cutera. 

J. Scott Boswell, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Boehringer Ingelheim. Speaker’s Bureau: AbbVie, Janssen, Pfizer, Sanofi/Regeneron, Dermavant, and Leo Pharma. 

Wendy Cantrell, CRNP, DNP, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Arcutis, LEO, and Lilly. Speaker’s Bureau: Sun Pharma. 

T J Chao, MPAS, PA-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Lilly. Speaker’s Bureau: AbbVie, Dermavant, Janssen, Lilly, Sun Pharma, BMS, Ortho Derm, Galderma, Leo Pharma, Amgen, Pfizer, Incyte, Regeneron/Sanofi, Arcutis, and UCB. 

Suneel Chilukuri, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerolase, Allergan, Benev, Galderma, Hydrinity, PCA Skin, Revance, Sente, Sciton, and Skin Medica. Grant/Research Support: Benev, Crown Aesthetics, InMode, Prollenium, and Revision Skin. Speaker’s List: AdvaTx, Aerolase, Allergan, Aesthetic Management Partners, Benev, Crown, Galderma, InMode, Prollenium, Hydrinity, PCA Skin, Revance, Sente Skin, Sciton, Skin Medica, and Revision Skin. Shareholder: Benev.

David Cohen, MD, MPH, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Ferndale Laboratories, Novartis, SFJ, FIDE, CIR, Leo, Dermavant, and UCB. Stock/Shareholder and Board of Directors: Evommune, and Timber. 

Adam Friedman, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Regeneron, Sanofi, Janssen, Novartis, Incyte, BMS, Galderma, Pfizer, Mino Labs, Abbvie, BI, LRP, and Aveeno. Grant/Research Support: Galderma, and Pfizer. Speaker’s Bureau: Regeneron, Sanofi, Janssen, Incyte, BMS, and Abbvie. Shareholder: Zylo and Microcures.

Brad Glick, DO, MPH, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisor: Abbvie, Amgen, Galderma, Sun Pharma, Leo Pharma, Lilly, Novartis, Dermavant Sciences, Incyte, EPI/Novan, BMS, Sanofi/Genzyme, Pfizer, Ortho Dermatologics, and UCB. Grant/Research Support: Abbvie, Amgen, AstraZeneca, Galderma, SUN Pharma, Lilly, Dermavant Science, BMS, Nimbus Lakshmi, Cara Therapeutics, Dermira, ChomoCentryx, Brickell Biotech, CorEvitas Registry PSO, CorEvitas Registry AD and PROSE Registry for AD. Speaker’s Bureau: AbbVie, Amgen, Janssen, Sun Pharma, Lilly, Novartis, Dermavant Sciences, Incyte, Epi/Novan, BMS, Dermira, Sanofi/Genzyme, Regeneron, Pfizer, Ortho Dermatologics, and UCB.

Kara S. Gooding, MMS, PA-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Janssen, Incyte, Leo, and UCB. Speaker’s Bureau: Eli Lilly, Janssen, Sun, Galderma, Almirall, Incyte, Leo, Arcutis, Pfizer, UCB, EpiHealth,a nd Amgen.

Joseph Gorelick, RN, MSN, FNP-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant and Speaker’s Bureau: Arcutis, BMS, Lilly, Incyte, Janssen, Leo Pharma, Novartis, Sanofi/Regeneron, Sun Pharma, and UCB. Speaker’s Bureau: Abbvie, Beiersdorf, Galderma, and Pfizer.

Steve Hawkes, MMS, PA-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Incyte, BMS, BCI, Impetus healthcare, and Novartis.

Jayme M. Heim, MSN, FNP-BC, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Arcutis, BMS, Boehringer Ingelheim, Lilly, Janssen, LEO Pharma, Novartis, Sanofi/Regeneron, and Dermavant. Speaker’s Bureau: AbbVie, Amgen, Arcutis, Beiersdorf, BMS, Janssen, Incyte, Lilly, LEO Pharma, Dermavant, SUN Pharma, and UCB. 

Michelle Hure, MD, has had a financial relationship or affiliation in the last two years with the following ineligible companies in the form of of Consultant/Speaker’s list: AbbVie, Amgen/Celgene, BMS, Incyte, Janssen, LEO Pharma, Lilly, and Regeneron/Sanofi.

Sandri Johnson, MSN, FNP-BC, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant/Speaker’s Bureau: AbbVie, Amgen, BMS, Incyte, Janssen, LEO Pharma, Lilly, UCB, Sanofi, Regeneron, Novartis, Arcutis, and Dermavant.

George Keough, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Dermavant, DermTech, Castle, Arcutis, and Biofrontera. Speaker’s Bureau: Dermavant. Shareholder: Pfizer and Regeneron.

Nellie Konnikov, MD, has had no financial relationships or affiliations with an ineligible company.

Kristine Kucera, PA-C, MPAS, DHS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, BMS, UCB, Novartis, and Dermavant. Speaker’s Bureau: Abbvie, Amgen, BMS, Janssen, Beiersdorf, Sun Pharma, Leo Pharma, and Pfizer.

Gilly Munavalli, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Candela, Sofwave, Lumenis, Allergan/Abbvie. 

Andrea Nguyen, MPAS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Amgen, BMS, Dermavant, EPI, Incyte, Janssen, Leo Pharma, Eli Lilly, Pfizer, Sun Pharma, UCB, Sanofi/Regeneron, Bausch/Orthdermatologics, Mayne, and Novartis. Grant/Research Support: Abbvie, Amgen, BMS, Dermavant, EPI, Incyte, Janssen, Leo Pharma, Eli Lilly, Pfizer, Sun Pharma, UCB, Sanofi/Regeneron, Alumis, Argenx, Bausch/Orthdermatologics, Galderma, Mayne, and Novartis. Shareholder: Abbvie, Amgen, Arcutis, BMS, Dermavant, EPI, Incyte, Janssen, Leo Pharma, Eli Lilly, Pfizer, Sun Pharma and UCB.

 Leigh Ann Pansch, MSN, FNP-BC, DCNP, has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s Bureat: Abbvie, Eli Lilly, Janssen, and Regeneron/Sanofi. 

Theodore Rosen, MD, has had no financial relationships or affiliations with an ineligible company.

Linda Stein Gold, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Arcutis, Amgen, BMS, Galderma, Dermavant, EPI, Abbvie, Pfizer, Lilly, Leo Pharma, and Incyte. Grant/Research Support: Arcutis, Amgen, BMS, Galderma, Dermavant, Abbvie, Pfizer, Lilly, Leo Pharma, and Incyte. Speaker’s Bureau: Arcutis, Amgen, BMS, Galderma, Dermavant, EPI, Abbvie, Pfizer, Lilly, Leo Pharma, and Incyte.

Darren West, MPAS, PA, has had a financial relationship or affiliation with the following ineligible companies in the form of Speaker’s List: Galderma, Pfizer, and Sun Pharma. 

Henry Yu, PA-C, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Abbvie, Galderma, Leo Pharma, UCB, Dermavant, and Arcustis. Speaker’s Bureau: Beiersdorf, Incyte, BMS, Dermavant, UCB, Boehringer Ingelhein, Galderma, Leo Pharma, Epi Health, Pfizer, and Sun Pharma. Grant/Research Support: Castle Bioscience.

The staff and planners of Evolve Medical Education, Dermatology Education Foundation and Physician Resources have no financial agreements with ineligible companies.